Serbia Accelerating Innovation and Entrepreneurship Project – SAIGE


The ‘Serbia Accelerating Innovation and Entrepreneurship Project (SAIGE)’ is crafted to offer support to institutions dedicated to enhancing the relevance and excellence of scientific research while empowering entrepreneurship in the Republic of Serbia. This initiative significantly contributes to the growth and competitiveness of the Serbian economy. Implemented under the joint auspices of the World Bank – International Bank for Reconstruction and Development (WB-IBRD) and the EU, the Ministry of Science, Technological Development, and Innovation of the Republic of Serbia serves as the coordinating entity for implementation within the country.

– The Reform of the Research Sector encompasses several key components, including supporting the functional transformation of scientific research institutions, financing programs of the Science Fund with a specific emphasis on fostering connections between the economic and academic sectors, promoting the development and enhancement of cooperation with the EU and the Serbian diaspora, reinforcing the Science Fund to ensure its sustainability, and elevating the skills of researchers to facilitate access to international sources of funding.

Development of Innovative Entrepreneurship rose incentives for collaboration with research organizations, providing technical assistance for mentorship in the context of innovative entrepreneurship, and the ‘business angels’ program.

– The development of innovative entrepreneurship involves incentivizing collaboration with research organizations, offering technical assistance for mentorship within the realm of innovative entrepreneurship, and implementing the ‘business angels’ program.

The transformation of the Institute of Virology, Vaccines, and Sera “Torlak

The objective of transforming the Institute “Torlak” with the support of the SAIGE project is to amplify the application potential of research results derived from basic research, aligning them with the developmental priorities of the Institute. By leveraging scientific results and innovations, the transformation aims to enhance the production and diagnostics capabilities of the Institute, ultimately elevating the quality of healthcare provided to the population. Moreover, this transformation seeks to boost visibility, recognizability, competitiveness in the international market, and overall societal progress.

Tremendous help throughout the entire transformation process has been provided by:

  • International Institutional Consultant
  • National Institutional Consultant
  • International Advisory Board

Schedule Analyses

Schedule

Institute "Torlak" is a long-standing producer of vaccines, serums, lactopreparations, allergens, microbiological media and immunodiagnostic preparations, recognizable on the world market for the quality, safety and efficiency of its products.

Our products